. Author manuscript; available in PMC: 2023 Nov 1.

Published in final edited form as: J Acquir Immune Defic Syndr. 2022 Nov 1;91(3):312–318. doi: 10.1097/QAI.0000000000003061

Table 3:

Coefficients of metabolites using lasso regression with cross validation. Metabolites shown are those that were selected for more than 50% of cross validation folds. Coefficients were averaged across folds.

	Metabolite	Average Coefficient	Proportion of Folds Selected
123	PC(34:4)	4.5729	1.0000
22	AC(10:0)	−1.7843	0.9615
105	PC(31:0)	2.9223	0.9615
33	AC(14:1)	−1.6489	0.9231
163	PC(41:2)	−1.9888	0.9231
79	CE(17:0)	−1.1589	0.8846
194	PC-O(33:6)	−0.7304	0.7692
113	PC(33:0)	0.9883	0.7308

AC = acylcarnitine, PC = phosphatidylcholine, CE = cholesterol ester